{
  "first_published_at": "2012-01-12", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON140702", 
  "title": "Public consultation on new pharmacovigilance legislation: how to comment", 
  "tags": "{\"parsed_therapeutic\": []}", 
  "_document_number": 123, 
  "label": null, 
  "icon": null, 
  "therapeutic_area": [], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Public consultation on new pharmacovigilance legislation: how to comment</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: January 2012</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!--We have launched a public consultation to seek views on the transposition into UK law of the EU Directive on pharmacovigilance-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>We have launched a public consultation to seek views on the transposition into UK law of the EU Directive on pharmacovigilance, which makes substantial changes to existing pharmacovigilance requirements and comes in to effect in July 2012.</p>\n\n<p>A key aim of the new legislation includes strengthening medicines safety transparency and communication to increase understanding and trust of healthcare professionals and patients in the safety of medicines, and improving penetration of key warnings.</p>\n\n<p>Comments are invited by Feb 28, 2012. Further information is <a target=\"_blank\" href=\"http://www.mhra.gov.uk/Publications/Consultations/Medicinesconsultations/MLXs/CON137667\">available here</a></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>We have launched a public consultation to seek views on the transposition into UK law of the EU Directive on pharmacovigilance, which makes substantial changes to existing pharmacovigilance requirements and comes in to effect in July 2012.</p>\n\n<p>A key aim of the new legislation includes strengthening medicines safety transparency and communication to increase understanding and trust of healthcare professionals and patients in the safety of medicines, and improving penetration of key warnings.</p>\n\n<p>Comments are invited by Feb 28, 2012. Further information is <a target=\"_blank\" href=\"http://www.mhra.gov.uk/Publications/Consultations/Medicinesconsultations/MLXs/CON137667\">available here</a></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2012-01-01", 
  "date_last_modified": "2012-01-12", 
  "_assets": [], 
  "_item_id": 123, 
  "summary": "", 
  "body": "Article date: January 2012\n\nWe have launched a public consultation to seek views on the transposition into UK law of the EU Directive on pharmacovigilance, which makes substantial changes to existing pharmacovigilance requirements and comes in to effect in July 2012.\n\nA key aim of the new legislation includes strengthening medicines safety transparency and communication to increase understanding and trust of healthcare professionals and patients in the safety of medicines, and improving penetration of key warnings.\n\nComments are invited by Feb 28, 2012. Further information is [available here](http://www.mhra.gov.uk/Publications/Consultations/Medicinesconsultations/MLXs/CON137667)\n"
}